Sino-Agri Leading Biosciences Co.,Ltd (SHA:603970)
China · Delayed Price · Currency is CNY 13.63
+0.12 (0.89%)
Feb 6, 2026, 3:00 PM CST
SHA:603970 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 11,031 | 10,596 | 10,460 | 11,699 | 8,822 | 6,641 | |
Revenue Growth (YoY) | 3.97% | 1.30% | -10.59% | 32.61% | 32.84% | 52.93% |
Cost of Revenue | 10,308 | 9,878 | 9,758 | 10,972 | 8,292 | 6,125 |
Gross Profit | 723.1 | 718.27 | 701.54 | 726.8 | 530.36 | 515.52 |
Selling, General & Admin | 341.74 | 321.85 | 320.13 | 294.73 | 248.88 | 233.88 |
Research & Development | 65.81 | 66.74 | 65.36 | 45.79 | 37.53 | 34.04 |
Other Operating Expenses | 0.41 | 0.04 | 6.88 | 9.38 | 10.58 | 3.45 |
Operating Expenses | 433.95 | 406.51 | 420.26 | 352.43 | 295.38 | 276.82 |
Operating Income | 289.15 | 311.76 | 281.28 | 374.37 | 234.99 | 238.71 |
Interest Expense | -20.92 | -22.44 | -16.6 | -26.76 | -33.84 | -44.95 |
Interest & Investment Income | 12.45 | 18.45 | 39.66 | 28.65 | 66.55 | 22.4 |
Currency Exchange Gain (Loss) | -0.03 | -0.03 | -16.22 | -15.19 | 13.87 | -22.57 |
Other Non Operating Income (Expenses) | -20.36 | -11.3 | 2.09 | -29.78 | -8.65 | -3.82 |
EBT Excluding Unusual Items | 260.29 | 296.43 | 290.21 | 331.3 | 272.92 | 189.78 |
Gain (Loss) on Sale of Investments | -1.6 | 1.26 | 11.83 | -18.55 | -13.55 | 17.57 |
Gain (Loss) on Sale of Assets | -0.37 | -0.58 | 0.71 | -0.77 | 0.3 | 0.39 |
Asset Writedown | 8.97 | -0.02 | -0.24 | 0.29 | -27.19 | -0.31 |
Other Unusual Items | 5.33 | 5.01 | 12.62 | 13.42 | 7.76 | 0.03 |
Pretax Income | 272.62 | 302.11 | 315.13 | 325.69 | 240.24 | 207.46 |
Income Tax Expense | 60.77 | 73.23 | 67.55 | 77.8 | 54.6 | 52.41 |
Earnings From Continuing Operations | 211.85 | 228.87 | 247.58 | 247.89 | 185.64 | 155.05 |
Minority Interest in Earnings | -32.34 | -25.5 | -22.74 | -37.57 | -15.33 | -22.61 |
Net Income | 179.51 | 203.38 | 224.84 | 210.32 | 170.31 | 132.44 |
Net Income to Common | 179.51 | 203.38 | 224.84 | 210.32 | 170.31 | 132.44 |
Net Income Growth | -17.71% | -9.55% | 6.91% | 23.49% | 28.59% | 11.41% |
Shares Outstanding (Basic) | 269 | 269 | 269 | 269 | 269 | 269 |
Shares Outstanding (Diluted) | 269 | 269 | 269 | 269 | 269 | 269 |
Shares Change (YoY) | 0.00% | 0.01% | -0.01% | 0.00% | -0.01% | -0.01% |
EPS (Basic) | 0.67 | 0.76 | 0.84 | 0.78 | 0.63 | 0.49 |
EPS (Diluted) | 0.67 | 0.76 | 0.84 | 0.78 | 0.63 | 0.49 |
EPS Growth | -17.71% | -9.55% | 6.92% | 23.48% | 28.60% | 11.42% |
Free Cash Flow | -864.59 | 305.21 | -948.57 | 1,532 | 321.43 | 337.13 |
Free Cash Flow Per Share | -3.22 | 1.14 | -3.53 | 5.70 | 1.20 | 1.25 |
Dividend Per Share | 0.450 | 0.450 | 0.450 | 0.393 | 0.250 | 0.214 |
Dividend Growth | - | - | 14.53% | 57.16% | 16.66% | 19.99% |
Gross Margin | 6.55% | 6.78% | 6.71% | 6.21% | 6.01% | 7.76% |
Operating Margin | 2.62% | 2.94% | 2.69% | 3.20% | 2.66% | 3.59% |
Profit Margin | 1.63% | 1.92% | 2.15% | 1.80% | 1.93% | 1.99% |
Free Cash Flow Margin | -7.84% | 2.88% | -9.07% | 13.10% | 3.64% | 5.08% |
EBITDA | 298.62 | 321.83 | 292.15 | 387.06 | 245.14 | 248.53 |
EBITDA Margin | 2.71% | 3.04% | 2.79% | 3.31% | 2.78% | 3.74% |
D&A For EBITDA | 9.47 | 10.07 | 10.87 | 12.68 | 10.15 | 9.82 |
EBIT | 289.15 | 311.76 | 281.28 | 374.37 | 234.99 | 238.71 |
EBIT Margin | 2.62% | 2.94% | 2.69% | 3.20% | 2.66% | 3.59% |
Effective Tax Rate | 22.29% | 24.24% | 21.44% | 23.89% | 22.73% | 25.26% |
Revenue as Reported | 11,031 | 10,596 | 10,460 | 11,699 | 8,822 | 6,641 |
Advertising Expenses | - | 55.36 | 48.03 | 40.44 | 25.83 | 25.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.